Literature DB >> 30797750

Reference intervals in the diagnosis of thyroid dysfunction: treating patients not numbers.

Jacqueline Jonklaas1, Salman Razvi2.   

Abstract

Although assigning a diagnosis of thyroid dysfunction appears quite simple, this is often not the case. Issues that make it unclear whether thyroid function is normal include transient changes in thyroid parameters, inter-individual and intra-individual differences in thyroid parameters, age-related differences, and ethnic variations. In addition, a statistically calculated distribution of thyroid analytes does not necessarily coincide with intervals or cutoffs that have predictive value for beneficial or adverse health outcomes. Based on current clincial trial data, it is unclear which individuals with mild thyroid-stimulating hormone elevations will benefit from levothyroxine treatment. For example, only a small number of patients with thyroid-stimulating hormone values of more than 10 mIU/L have been studied in a randomised manner. Even if therapy is initiated for abnormal thyroid function, not all treated individuals are maintained at the desired treatment target, and therefore might still be at risk. The consequence of this is that each patient's thyroid function needs to be assessed on an individual basis with the entire clinical picture in mind. Monitoring also needs to be vigilant, and the targets for treatment reassessed continually.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30797750     DOI: 10.1016/S2213-8587(18)30371-1

Source DB:  PubMed          Journal:  Lancet Diabetes Endocrinol        ISSN: 2213-8587            Impact factor:   32.069


  22 in total

Review 1.  Diagnosis and treatment of hypothyroidism in the elderly.

Authors:  Leonidas H Duntas; Paul Michael Yen
Journal:  Endocrine       Date:  2019-09-03       Impact factor: 3.633

2.  Age-Related Serum Thyroid-Stimulating Hormone Reference Range in Older Patients Treated with Levothyroxine: A Randomized Controlled Feasibility Trial (SORTED 1).

Authors:  Salman Razvi; Vicky Ryan; Lorna Ingoe; Simon H Pearce; Scott Wilkes
Journal:  Eur Thyroid J       Date:  2019-11-21

Review 3.  Hypothyroidism.

Authors:  Layal Chaker; Salman Razvi; Isabela M Bensenor; Fereidoun Azizi; Elizabeth N Pearce; Robin P Peeters
Journal:  Nat Rev Dis Primers       Date:  2022-05-19       Impact factor: 52.329

4.  Optimal Thyroid Hormone Replacement.

Authors:  Jacqueline Jonklaas
Journal:  Endocr Rev       Date:  2022-03-09       Impact factor: 25.261

Review 5.  The Clinical Relevance of Hypothyroidism in Patients with Solid Non-Thyroid Cancer: A Tantalizing Conundrum.

Authors:  Maria V Deligiorgi; Dimitrios T Trafalis
Journal:  J Clin Med       Date:  2022-06-14       Impact factor: 4.964

6.  Prevalence and Risk Factors of Thyroid Dysfunction in Older Adults in the Community.

Authors:  Nermin Diab; Natalie R Daya; Stephen P Juraschek; Seth S Martin; John W McEvoy; Ulla T Schultheiß; Anna Köttgen; Elizabeth Selvin
Journal:  Sci Rep       Date:  2019-09-11       Impact factor: 4.379

Review 7.  The Swinging Pendulum in Treatment for Hypothyroidism: From (and Toward?) Combination Therapy.

Authors:  Elizabeth A McAninch; Antonio C Bianco
Journal:  Front Endocrinol (Lausanne)       Date:  2019-07-09       Impact factor: 5.555

Review 8.  Challenges in Interpreting Thyroid Stimulating Hormone Results in the Diagnosis of Thyroid Dysfunction.

Authors:  Salman Razvi; Sindeep Bhana; Sanaa Mrabeti
Journal:  J Thyroid Res       Date:  2019-09-22

Review 9.  To Treat or Not to Treat Subclinical Hypothyroidism, What Is the Evidence?

Authors:  Jan Calissendorff; Henrik Falhammar
Journal:  Medicina (Kaunas)       Date:  2020-01-19       Impact factor: 2.430

10.  Study of reference intervals for free triiodothyronine, free thyroxine, and thyroid-stimulating hormone in an elderly Chinese Han population.

Authors:  Jingting Xiong; Shiguo Liu; Kai Hu; Yinxiang Xiong; Pengyun Wang; Liang Xiong
Journal:  PLoS One       Date:  2020-09-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.